Scarica l'app Stockscreener
3.42
2.29%
-0.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.50
Aprire:
$3.44
Volume 24 ore:
126.83K
Relative Volume:
0.61
Capitalizzazione di mercato:
$51.08M
Reddito:
$37.79M
Utile/perdita netta:
$-10.38M
Rapporto P/E:
-4.6849
EPS:
-0.73
Flusso di cassa netto:
$-1.00M
1 W Prestazione:
-29.34%
1M Prestazione:
-11.17%
6M Prestazione:
+0.59%
1 anno Prestazione:
-46.31%
Intervallo 1D:
$3.30
$3.552
Intervallo di 1 settimana:
$3.30
$4.80
Portata 52W:
$1.85
$6.39
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Nome
Cumberland Pharmaceuticals Inc
Settore
Telefono
615-255-0068
Indirizzo
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.415 | 52.35M | 37.79M | -10.38M | -1.00M | -0.73 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.09 | 56.49B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
122.14 | 51.26B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.27 | 45.79B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.23 | 36.16B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
527.86 | 20.96B | 3.13B | 1.27B | 1.12B | 26.39 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2012-11-12 | Reiterato | UBS | Neutral |
| 2011-02-01 | Reiterato | UBS | Neutral |
| 2010-12-16 | Downgrade | UBS | Buy → Neutral |
| 2010-08-17 | Downgrade | Jefferies | Buy → Hold |
| 2010-08-17 | Reiterato | Morgan Joseph | Buy |
| 2010-08-17 | Reiterato | UBS | Buy |
| 2010-05-14 | Reiterato | Morgan Joseph | Buy |
Mostra tutto
Cumberland Pharmaceuticals Inc Borsa (CPIX) Ultime notizie
Cumberland Pharmaceuticals 2025 10-K — Revenue $44.5M, Net loss $2.9M - TradingView
Swing Trade: What is the dividend yield of Cumberland Pharmaceuticals IncPortfolio Risk Summary & Low Risk High Reward Trade Ideas - baoquankhu1.vn
How resilient is Cumberland Pharmaceuticals Inc. stock in market downturns2026 Rallies & Low Volatility Stock Recommendations - Naître et grandir
Risk Recap: Will Cumberland Pharmaceuticals Inc announce a stock splitJuly 2025 Catalysts & Short-Term High Return Ideas - baoquankhu1.vn
Aug Highlights: Can Cumberland Pharmaceuticals Inc reach all time highs this year - baoquankhu1.vn
Momentum Shift: Is Cumberland Pharmaceuticals Inc in a bullish channelTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Pale Fire Capital Bets Big on Healthcare With a 2.07 Million Share Baxter International (BAX) Investment - AOL.com
1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth - AOL.com
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance - AOL.com
CPIX SEC FilingsCumberland Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection - AOL.com
CPIX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cumberland Pharmaceuticals Reports 31% Q4 2025 Revenue Growth, Expands Internationally, and Achieves Key Clinical and Financial Milestones - Minichart
Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com
Cumberland: Fourth Quarter Financial Results Overview - Bitget
Earnings call transcript: Cumberland Pharmaceuticals Q4 2025 sees revenue surge - Investing.com
Cumberland Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Cumberland: Q4 Earnings Snapshot - GreenevilleSun.com
Cumberland Pharmaceuticals 2025 revenue rises - TradingView
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH - PR Newswire
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale - AOL.com
Joint U.S. Commercialization of RedHill's Talicia® Commences - marketscreener.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
H. pylori drug Talicia rolls out in U.S. as infection hits 35% of adults - Stock Titan
Cumberland Pharma schedules Mar. 3 call on 2025 results and company update - Stock Titan
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE - Yahoo Finance
Volume Report: Why is Cumberland Pharmaceuticals Inc stock going upWeekly Trend Recap & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge - AOL.com
Merger Talk: Can Cumberland Pharmaceuticals Inc reach all time highs this yearPrice Action & Weekly Top Performers Watchlists - baoquankhu1.vn
Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress - AOL.com
Why is Cumberland Pharmaceuticals Inc. stock going upCPI Data & AI Enhanced Trading Signals - mfd.ru
Why ImmunityBio Stock Is Soaring Today - AOL.com
Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead - Intellectia AI
Why Did Compass Pathways Stock Rocket Higher Today? - AOL.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Will Cumberland Pharmaceuticals Inc. announce a stock splitQuarterly Market Review & Accurate Trade Setup Notifications - mfd.ru
Momentum Shift: Is Cumberland Pharmaceuticals Inc stock a top performer YTDJuly 2025 Short Interest & Safe Entry Point Alerts - baoquankhu1.vn
Portfolio Shifts: What is the dividend yield of Cumberland Pharmaceuticals IncEarnings Risk Report & Capital Protection Trading Alerts - baoquankhu1.vn
What is the dividend yield of Cumberland Pharmaceuticals Inc.Quarterly Performance Summary & High Win Rate Trade Tips - mfd.ru
Why Cumberland Pharmaceuticals Inc. stock is favored by top institutionsRisk Management & Intraday High Probability Alerts - mfd.ru
Little Excitement Around Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Revenues As Shares Take 31% Pounding - simplywall.st
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Bristol Myers Just Crushed Earnings, and the Real Catalyst Hasn’t Even Hit Yet - AOL.com
FDA fast tracks Dyscorban for treating heart problems in Duchenne - Muscular Dystrophy News
Ideas Watch: Why is Cumberland Pharmaceuticals Inc stock going upEarnings Miss & Long Hold Capital Preservation Tips - baoquankhu1.vn
FDA fast tracks Cumberland’s DMD heart disease therapy By Investing.com - Investing.com Nigeria
Cumberland Pharmaceuticals Wins Fast Track for Ifetroban - TipRanks
Cumberland Pharmaceuticals Receives FDA Fast Track Designation for DMD Therapy - TradingView
FDA fast tracks Cumberland’s DMD heart disease therapy - Investing.com
Cumberland Pharmaceuticals shares rise on FDA fast track status for DMD drug By Investing.com - Investing.com South Africa
Cumberland Pharmaceuticals Inc Azioni (CPIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
7.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):